Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimized glycemic control and early remission in newly diagnosed type 2 diabetes
PACTR202009815264860Completed
- Sponsor
- IRESSEF
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of human insulin in type 2 diabetes mellitus (T2DM), sponsored by IRESSEF. Primary endpoint: Change in insulin sensitivity. Started Oct 2016; status: completed.
02
Drugs
human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on PACTR202009815264860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202009815264860.